Critical Reviews in Oncology/Hematology

Title Publication Date Language Citations
Comment on “A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinoma”2023/09/01English
Editorial Board2023/08/01English
Challenges in the management of primary central nervous system lymphoma2023/08/01English
Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma2023/08/01English
Editorial Board2023/02/01English
Radon and Lung Cancer: Current Status and Future Prospects2024/04/01English
Bortezomib-induced peripheral neuropathy: Clinical features, molecular basis, and therapeutic approach2024/05/01English
What is the association of preoperative biopsy with recurrence and survival in retroperitoneal sarcoma? A systematic review by the Australia and New Zealand Sarcoma Association clinical practice guidelines working party2024/05/01English
What is the role of physical exercise in the era of cancer prehabilitation? A systematic reviewEnglish
Research update for ferroptosis and cholangiocarcinomaEnglish
Association of PD-L1 expression with survival benefit from PD-1/PD-L1 inhibitors in advanced cancer: Systematic review and meta-analysis of phase III randomized clinical trialsEnglish
The crosstalk between oncogenic signaling and ferroptosis in cancer2024/05/01English
C-reactive protein (CRP) as a prognostic biomarker in patients with urothelial carcinoma: A systematic review and meta-analysis2024/05/01English
Trastuzumab deruxtecan in breast cancerEnglish
The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma2024/05/01English
Prevention of cervix cancer2000/03/01English
A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?2024/04/01English
Prevention of lung cancer2000/03/01English
Prevention of breast cancer2000/03/01English
Telomerase: a therapeutic target for the third millennium?2000/05/01English
Chemoprevention: general perspective2000/03/01English
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies2024/04/01English
Adjuvant therapy for renal cell carcinoma: A systematic review of current landscape and future directions2023/12/01English
Evaluation of clinical decision support systems in oncology: An updated systematic review2023/12/01English
Delta-like ligand 3 in small cell lung cancer: Potential mechanism and treatment progress2023/11/01English
Bladder-sparing treatment for muscle-invasive bladder carcinoma using immune checkpoint inhibitors2023/11/01English
Smart nano-sized extracellular vesicles for cancer therapy: Potential theranostic applications in gastrointestinal tumors2023/11/01English
Instruments and scales for the evaluation of acute radiation dermatitis: A systematic review2023/11/01English
Editorial Board2023/09/01English
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab2023/10/01English